2McMahon E G. Recent studies with eplerenone,a novel selective Aldosterone receptor antagonist [J]. Curr Opin Pharmacol,2001,20(1) :190-196.
3Ramires F J, Mansure A, Coelho O, et al. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy[J]. Am J Cardiol, 2000,85 ( 10 ): 1207 - 1211.
7Brilla CG,Sehencking M,Seheer C,et al.Spironolactone:renaissnne of anti-aldosterone therapy in heart failure?[J].Sehweiz Rnndsch Med Prax,1997,86(14):566-574.
8Mac Fayden RJ,Barr CS,Struthers AD.Aldosterone blockade reduces vascular collagen turnover,improves heart rate variability and reduce searly morning rise in heart rate in heart failure patients[J].Cardiovasc Res,1997,35:30-34.
9Kenneth C,Bilchick MD,Barry Feties MSE,et al.Prognostic value of heart rate variability in chronic congestive heart failure(veterans affairs suvival trial of antiarrhythmic therapy in congestive heart failure)[J].Am J Cardiol,2002,90(1):24-28.
10Packer M, Poole-Wilson PA. Comparative effects of low and high doses of the aniotensin-converting enzyme inhibitor, lisinopril, on mobidity and mortality in chronic heart failure. Circulation, 1999, 100(23) :2312-2318.
